Market Price

35.99 

-0.99 -2.7%

as of Feb 25 '21

52 Week Range:

4.05 40.78


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, and vitamins and supplements to wholesale and retail customers. The company also offers value-added practice solutions that include financial services, equipment repair, inventory management, and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as e-commerce, shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company, formerly known as HS Spinco, Inc., was incorporated in 2018 and is headquartered in Portland, Maine.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Equity (BVPS) 11.91
growth rate
Earnings BIT 112.15
131.10
135.00
209.74
-797.00
growth rate 16.9% 3.0% 55.4% -100.0%
Avg.PE 23.32
33.87
growth rate 45.2%
ROA 3.61
-0.89
4.58
-36.43
growth rate -100.0% 100.0% -100.0%
ROE 6.52
-1.60
7.45
-74.12
growth rate -100.0% 100.0% -100.0%
ROIC 6.36
-1.56
7.32
-49.00
growth rate -100.0% 100.0% -100.0%
Cur. Ratio 2.00
2.11
1.90
1.62
growth rate 5.5% -10.0% -14.7%
Quick Ratio 0.95
1.02
0.88
0.75
growth rate 7.4% -13.7% -14.8%
Leverage 1.80
1.79
1.50
2.68
growth rate -0.6% -16.2% 78.7%
Balance Sheet Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Acct.Receivable 423.69
503.52
480.00
493.00
growth rate 18.8% -4.7% 2.7%
Acct.Payable 341.19
375.78
440.00
520.00
growth rate 10.1% 17.1% 18.2%
Cur.Assets 932.28
1,076.93
1,086.00
1,340.00
growth rate 15.5% 0.8% 23.4%
Total Assets 1,944.99
2,217.02
2,233.08
3,361.00
growth rate 14.0% 0.7% 50.5%
Cash 19.71
16.66
23.32
130.00
growth rate -15.5% 40.0% 457.4%
Inventory 473.66
534.66
564.00
636.00
growth rate 12.9% 5.5% 12.8%
Cur.Liabilities 466.15
511.59
572.00
829.00
growth rate 9.8% 11.8% 44.9%
Liabilities 544.16
593.23
739.47
2,105.00
growth rate 9.0% 24.7% 184.7%
LT Debt 24.36
22.21
23.53
1,125.00
growth rate -8.8% 5.9% 4,681.3%
Equity 1,078.76
1,257.24
1,493.62
1,256.00
growth rate 16.5% 18.8% -15.9%
Common Shares 111.00
111.00
111.00
72.00
107.00
growth rate 0.0% 0.0% -35.1% 48.6%
Cash Flow Statement Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Capital Expenditures 9.29
12.75
21.00
22.03
39.00
growth rate 37.2% 64.7% 4.9% 77.1%
Cash Dividends 1,174.00
1,174.00
1,174.00
1,174.00
growth rate 0.0% 0.0% 0.0%
Cash From OA 96.12
104.80
108.00
158.00
103.00
growth rate 9.0% 3.1% 46.3% -34.8%
FCF per Share 0.82
growth rate
Sale Purchase of Stock 5.00
growth rate
FCF 87.00
92.00
88.00
136.00
64.00
growth rate 5.8% -4.4% 54.6% -52.9%
Income Statement Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Sales 2,978.33
3,353.16
3,580.00
3,777.99
3,976.00
growth rate 12.6% 6.8% 5.5% 5.2%
Op.Income 112.15
131.10
135.00
145.64
-59.00
growth rate 16.9% 3.0% 7.9% -100.0%
IBT 109.26
128.20
140.00
143.18
-1,029.00
growth rate 17.3% 9.2% 2.3% -100.0%
Net Income 60.32
70.30
64.00
100.86
-1,019.00
growth rate 16.5% -9.0% 57.6% -100.0%
EPS 0.54
0.63
0.58
0.91
-9.50
growth rate 16.7% -7.9% 56.9% -100.0%
Gross Profit 530.02
619.91
652.00
684.11
749.00
growth rate 17.0% 5.2% 4.9% 9.5%

Quarterly Statements

Item Name Sep '19 Dec '19 Mar '20 Jun '20 Sep '20
Earnings BIT -905.00
24.00
19.00
127.00
26.00
growth rate 100.0% -20.8% 568.4% -79.5%
Balance Sheet Sep '19 Dec '19 Mar '20 Jun '20 Sep '20
Acct.Receivable 466.00
493.00
595.00
545.00
579.00
growth rate 5.8% 20.7% -8.4% 6.2%
Acct.Payable 483.00
520.00
466.00
429.00
416.00
growth rate 7.7% -10.4% -7.9% -3.0%
Cur.Assets 1,244.00
1,340.00
1,460.00
1,484.00
1,500.00
growth rate 7.7% 9.0% 1.6% 1.1%
Total Assets 3,328.00
3,361.00
3,487.00
3,526.00
3,510.00
growth rate 1.0% 3.8% 1.1% -0.5%
Cash 68.00
130.00
205.00
414.00
355.00
growth rate 91.2% 57.7% 102.0% -14.3%
Inventory 598.00
636.00
572.00
484.00
521.00
growth rate 6.4% -10.1% -15.4% 7.6%
Cur.Liabilities 751.00
829.00
800.00
720.00
731.00
growth rate 10.4% -3.5% -10.0% 1.5%
Liabilities 1,999.00
2,105.00
2,285.00
2,250.00
2,094.00
growth rate 5.3% 8.6% -1.5% -6.9%
LT Debt 1,141.00
1,125.00
1,298.00
1,103.00
1,088.00
growth rate -1.4% 15.4% -15.0% -1.4%
Equity 1,329.00
1,256.00
1,202.00
1,276.00
1,416.00
growth rate -5.5% -4.3% 6.2% 11.0%
Common Shares 112.00
107.00
112.00
1.00
1.00
growth rate -4.5% 4.7% -99.1% 0.0%
Cash Flow Statement Sep '19 Dec '19 Mar '20 Jun '20 Sep '20
Capital Expenditures 9.00
9.00
11.00
13.00
16.00
growth rate 0.0% 22.2% 18.2% 23.1%
Cash Dividends 0.00
0.00
0.00
2.00
4.00
growth rate 100.0%
Cash From OA 30.00
70.00
-76.00
130.00
-43.00
growth rate 133.3% -100.0% 100.0% -100.0%
Sale Purchase of Stock 4.00
5.00
growth rate 25.0%
FCF 21.00
61.00
-87.00
117.00
-59.00
growth rate 190.5% -100.0% 100.0% -100.0%
Income Statement Sep '19 Dec '19 Mar '20 Jun '20 Sep '20
Sales 1,018.00
1,008.00
1,065.00
1,026.00
1,126.00
growth rate -1.0% 5.7% -3.7% 9.8%
Op.Income -19.00
-26.00
-20.00
-4.00
-27.00
growth rate 0.0% 0.0% 0.0% 0.0%
IBT -969.00
-37.00
-35.00
59.00
-32.00
growth rate 0.0% 0.0% 100.0% -100.0%
Net Income -906.00
-90.00
-33.00
54.00
-35.00
growth rate 0.0% 0.0% 100.0% -100.0%
Gross Profit 197.00
172.00
202.00
192.00
197.00
growth rate -12.7% 17.4% -5.0% 2.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (0.00)

YOY Growth Grade:

E (22.39)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is negative, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE 33.87 -69.61 39.08
EPS / Growth -0.52 51.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 26.0% 26.0%
Future PE 2.00 41.65 41.65
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT 99.00 99.00 99.00

Graham Number:

Current EPS is negative, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.